المؤلفون: Innes AL; FHI 360 Asia Pacific Regional Office, Bangkok, Thailand. anh.innes@gmail.com., Lebrun V; FHI 360 Vietnam, Hanoi, Vietnam., Hoang GL; FHI 360 Vietnam, Hanoi, Vietnam., Martinez A; FHI 360, Durham, NC, USA., Dinh N; FHI 360, Durham, NC, USA., Nguyen TTH; FHI 360 Vietnam, Hanoi, Vietnam., Huynh TP; FHI 360 Vietnam, Hanoi, Vietnam., Quach VL; FHI 360 Vietnam, Hanoi, Vietnam., Nguyen TB; FHI 360 Vietnam, Hanoi, Vietnam., Trieu VC; FHI 360 Vietnam, Hanoi, Vietnam., Tran NDB; FHI 360 Vietnam, Hanoi, Vietnam., Pham HM; U.S. Agency for International Development/Vietnam, Hanoi, Vietnam., Dinh VL; Vietnam National Lung Hospital, Hanoi, Vietnam., Nguyen BH; Vietnam National Lung Hospital, Hanoi, Vietnam., Truong TTH; Vietnam National Lung Hospital, Hanoi, Vietnam., Nguyen VC; Vietnam National Lung Hospital, Hanoi, Vietnam., Nguyen VN; Vietnam National Lung Hospital, Hanoi, Vietnam.; Pulmonology Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam., Mai TH; FHI 360 Vietnam, Hanoi, Vietnam.

المصدر: Global health, science and practice [Glob Health Sci Pract] 2024 Jun 27; Vol. 12 (3). Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: U.S. Agency for International Development and Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs Country of Publication: United States NLM ID: 101624414 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2169-575X (Electronic) Linking ISSN: 2169575X NLM ISO Abbreviation: Glob Health Sci Pract Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control, Humans ; Vietnam/epidemiology ; Tuberculosis, Pulmonary/diagnosis ; Tuberculosis, Pulmonary/prevention & control ; Tuberculosis, Pulmonary/epidemiology ; Mass Screening/organization & administration ; Mass Screening/methods ; SARS-CoV-2 ; Middle Aged ; Radiography, Thoracic ; Tuberculosis/diagnosis ; Tuberculosis/prevention & control ; Tuberculosis/epidemiology ; Female ; Pandemics ; Male ; Vulnerable Populations

المؤلفون: Innes AL; FHI 360 Asia Pacific Regional Office, Bangkok 10330, Thailand., Martinez A; FHI 360, Durham, NC 27701, USA., Gao X; FHI 360, Durham, NC 27701, USA., Dinh N; FHI 360, Durham, NC 27701, USA., Hoang GL; FHI 360 Vietnam, Hanoi 10000, Vietnam., Nguyen TBP; FHI 360 Vietnam, Hanoi 10000, Vietnam., Vu VH; FHI 360 Vietnam, Hanoi 10000, Vietnam., Luu THT; FHI 360 Vietnam, Hanoi 10000, Vietnam., Le TTT; FHI 360 Vietnam, Hanoi 10000, Vietnam., Lebrun V; FHI 360 Vietnam, Hanoi 10000, Vietnam., Trieu VC; FHI 360 Vietnam, Hanoi 10000, Vietnam., Tran NDB; FHI 360 Vietnam, Hanoi 10000, Vietnam., Qin ZZ; Stop TB Partnership, Grand-Saconnex, 1218 Geneva, Switzerland., Pham HM; United States Agency for International Development/Vietnam, Hanoi 10000, Vietnam., Dinh VL; Vietnam National Lung Hospital, Hanoi 10000, Vietnam., Nguyen BH; Vietnam National Lung Hospital, Hanoi 10000, Vietnam., Truong TTH; Vietnam National Lung Hospital, Hanoi 10000, Vietnam., Nguyen VC; Vietnam National Lung Hospital, Hanoi 10000, Vietnam., Nguyen VN; Vietnam National Lung Hospital, Hanoi 10000, Vietnam.; Pulmonology Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi 10000, Vietnam., Mai TH; FHI 360 Vietnam, Hanoi 10000, Vietnam.

المصدر: Tropical medicine and infectious disease [Trop Med Infect Dis] 2023 Oct 29; Vol. 8 (11). Date of Electronic Publication: 2023 Oct 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101709042 Publication Model: Electronic Cited Medium: Internet ISSN: 2414-6366 (Electronic) Linking ISSN: 24146366 NLM ISO Abbreviation: Trop Med Infect Dis Subsets: PubMed not MEDLINE

المؤلفون: Innes AL; FHI 360 Asia Pacific Regional Office, Bangkok, Thailand., Nguyen ST; University of California, San Francisco, CA, USA., Lebrun V; FHI 360 Vietnam, Hanoi, Vietnam., Nguyen TTH; FHI 360 Vietnam, Hanoi, Vietnam., Huynh TP; FHI 360 Vietnam, Hanoi, Vietnam., Quach VL; FHI 360 Vietnam, Hanoi, Vietnam., Hoang GL; FHI 360 Vietnam, Hanoi, Vietnam., Nguyen TB; FHI 360 Vietnam, Hanoi, Vietnam., Nguyen TBP; FHI 360 Vietnam, Hanoi, Vietnam., Pham HM; United States Agency for International Development Vietnam, Hanoi, Vietnam., Martinez A; FHI 360, Durham, NC, USA., Dinh N; FHI 360, Durham, NC, USA., Dinh VL; Vietnam National Lung Hospital/National Tuberculosis Programme Hanoi, Vietnam., Nguyen BH; Vietnam National Lung Hospital/National Tuberculosis Programme Hanoi, Vietnam., Truong TTH; Vietnam National Lung Hospital/National Tuberculosis Programme Hanoi, Vietnam., Nguyen VC; Vietnam National Lung Hospital/National Tuberculosis Programme Hanoi, Vietnam., Nguyen VN; Vietnam National Lung Hospital/National Tuberculosis Programme Hanoi, Vietnam., Mai TH; FHI 360 Vietnam, Hanoi, Vietnam.

المصدر: Public health action [Public Health Action] 2023 Sep 21; Vol. 13 (3), pp. 83-89.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Union Against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 101624961 Publication Model: Print Cited Medium: Print ISSN: 2220-8372 (Print) Linking ISSN: 22208372 NLM ISO Abbreviation: Public Health Action Subsets: PubMed not MEDLINE

المؤلفون: Tran TNM; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., May BP; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Ung TT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Nguyen MK; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Nguyen TTT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Dinh VL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Doan CC; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Tran TV; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Khong H; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Nguyen TTT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Hua HQH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Nguyen VA; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Ha TP; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Phan DL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Nguyen TA; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Bui TN; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Tu TM; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Nguyen TT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Le TTH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Dong TL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Huynh TH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Ho PH; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Le NTT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Truong CT; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Pham HP; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Luong CY; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Y NL; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Cao MN; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Nguyen DK; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam., Le TT; Department of Virology, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam., Vuong DC; Department of Virology, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam., Nguyen LKH; Department of Virology, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam., Do MS; Department of Research and Development, Nanogen Pharmaceutical Biotechnology Joint Stock Company (JSC), Ho Chi Minh City, Vietnam.

المصدر: Frontiers in immunology [Front Immunol] 2021 Dec 06; Vol. 12, pp. 766112. Date of Electronic Publication: 2021 Dec 06 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19/*prevention & control , COVID-19 Vaccines/*immunology , COVID-19 Vaccines/*toxicity , Immunogenicity, Vaccine/*immunology , Spike Glycoprotein, Coronavirus/*immunology, Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Cricetinae ; Macaca ; Mice ; Rats ; SARS-CoV-2 ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/toxicity